Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-05-19 @ 12:45 PM
Study NCT ID:
NCT00858234
Status:
COMPLETED
Last Update Posted:
2021-04-09
First Post:
2009-03-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0683-098
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None